• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Third party research

Elanders: Margin story confirmed in Q4 - Nordea

Elanders

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
We raise adjusted EBITA by 2% for 2026E-27E, following the stronger-than-expected profitability in Q4, with adjusted EBITA increasing 8% y/y despite a 19% y/y sales decline. Although Q4 marked an inflection point in earnings, we look for this to take a significant leap upwards in H1 2026 – reaching ~41% y/y – bolstered by easier comps. Additionally, the 220bp y/y margin uplift in the Q4 2025 report clearly confirms our view of the ongoing margin trajectory for Elanders in SCS. Coupled with a volume recovery in the upcoming years, supporting improved capacity utilisation across the group, we expect Elanders to better capitalise on rebounding demand. We look for an 11% adjusted EBITA CAGR for 2025-27E. Although the Q4 cash flow was a slight disappointment, burdened by the WC tie-up, this ought to revert as early as in Q1. Along with strong earnings growth in 2026E, we pencil in lease adjusted net debt/EBITDA of 2.8x for 2026. We derive a higher multiples-based fair value range of SEK 52-97 (49-89), implying 2026E EV/EBITA of 10-12x.